Primer: Hangzhou Sciwind Biosciences (HSB HK) - Aug 2026
Hangzhou Sciwind Biosciences is a clinical-stage biopharmaceutical company on the verge of commercialization, with a strong focus on the...
89 Views
Pre-IPO Hangzhou Sciwind Biosciences - Thoughts About the Industry and The GLP-1 Pipeline
Due to fierce competition, Sciwind's pipeline face challenges in head-to-head trial/commercialization.Peak sales of XW003/XW004/XW014 estimated at...
518 Views
No more insights